🔴 KURE is trading 3.15% down today as Hong Kong CRO stocks slide

KURE is trading 3.15% down at $17.53 as Chinese healthcare shares and broader Chinese equities come under pressure.

• On October 22, Hong Kong-listed CRO stocks fell broadly: WuXi Biologics dropped 8.26%, while WuXi AppTec and GenScript fell more than 6%; all are among KURE’s holdings.
• The CSI 300 was more than 1% lower and entered bear-market territory amid concerns about earnings and AI-related valuations.
• The move points to sector and market pressure rather than a KURE-specific announcement.